Quality of Life in Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy

张亚茹,孙玉梅,李燕琴,张卫华,王征,王楠
DOI: https://doi.org/10.13267/j.cnki.syzlzz.2014.06.013
2014-01-01
Abstract:Objective To assess the quality of life in lung cancer patients undergoing concurrent chemoradiotherapy.Methods Sixty-six patients with lung cancer underwent concurrent chemoradiotherapy.The quality of life of patients was evaluated with EORTC QLQ-C30(Chinese version) before treatment(T0),at the end of treatment(T1) and one month after treatment(T2).Results The scores of overall quality of life(QOL) at T0,T1 and T2 were73.11 ± 22.40,51.22 ± 26.05 and 67.80 ± 18.19(P 0.01),respectively.The scores of all functional dimensions decreased shortly at the end of concurrent chemoradiotherapy(T1),but increased one month after the treatment(T2),with most of them close to pre-treatment levels.The symptoms of fatigue,pain,insomnia,dyspnea and anorexia were worsened at T1(all P 0.05) and improved at T2(all P 0.05,except for insomnia) though still worse than those at T0(all P 0.05,except for insomnia and dyspnea).Conclusion The quality of life in lung cancer patients is relatively well before concurrent chemoradiotherapy,and chemo-radiation may induce a temporary and reversible decline in QOL.
What problem does this paper attempt to address?